How AI Can Lead to a Healthier Brain
Mild cognitive impairment (MCI) is the term medical professionals use to describe a person’s first…
Kalahasty is the Co-Founder and CEO of Vytal.ai. He has been a researcher at the Harvard Ophthalmology AI Lab for three years, where he led and incubated NeurOS and worked on projects leveraging mathematical, statistical, and artificial intelligence modeling to enhance eye disease diagnosis. Furthermore, he served as an incubation lead at Roivant Sciences, leading the early stages of a potential new vant. He has also researched at the Center for Brains, Minds, and Machines at MIT, where he dedicated his time to studying human intelligence and memory utilizing artificial intelligence. While working with these groups, he has developed a deep insight into the intersection of AI and Medicine and the creation of digital biomarkers, an insight which has proved crucial for the development of Vytal. He has a focus on interdisciplinary endeavors that have the potential to make an impact in the world. He is a senior at Thomas Jefferson High School for Science and Technology.
Mild cognitive impairment (MCI) is the term medical professionals use to describe a person’s first…